Hikal

** Shares of India's Hikal HIKA.NS fall 9.41% to 200.49 rupees

** The pharmaceutical firm's fourth-quarter consol net profit came in at 144 million rupees ($1.51 million), down from 502 million rupees a year earlier

** Revenue from operations down 6% y/y

** Company posts a one-time impairment charge of 471 million rupees related to re-purposing of a manufacturing plant

** YTD, stock down around 10.5%

($1 = 95.5725 Indian rupees)

(Reporting by Bipasha Dey in Bengaluru)

(([email protected];))

May 27 (Reuters) - Hikal Ltd HIKA.NS:

• HIKAL LTD MARCH-QUARTER CONSOL NET PROFIT 144 MILLION RUPEES

• HIKAL LTD MARCH-QUARTER CONSOL TOTAL REVENUE FROM OPERATIONS 5.19 BILLION RUPEES

Source text: [ID:]

Further company coverage: HIKA.NS

(([email protected];))

Nov 13 (Reuters) - Hikal Ltd HIKA.NS:

• SEPT-QUARTER CONSOL LOSS 349 MILLION RUPEES

• SEPT-QUARTER CONSOL TOTAL REVENUE FROM OPERATIONS 3.19 BILLION RUPEES

Source text: ID:nBSE3f7LMH

Further company coverage: HIKA.NS

(([email protected];))

** Shares of Hikal Ltd HIKA.NS drop 2.4% to 249 rupees, down for a sixth consecutive session

** The pharmaceutical ingredients maker disclosed a warning letter on Friday from the U.S. FDA for "inadequate investigations of customer complaints on foreign matter"

** HIKA flags potential delay of revenue flow into second half of fiscal 2026

** Co adds that it has taken corrective actions and informed the U.S. FDA of the same

** Stock down 36% so far this year

(Reporting by Nandan Mandayam in Bengaluru)

(([email protected]; Mobile: +91 9591011727;))

** Shares of pharmaceutical company Hikal HIKA.NS fall 2.2% to 248 rupees, on track for its third straight session of losses

** Co receives warning letter from US FDA for it's manufacturing facility in Jigani, Bengaluru

** US FDA inspected the facility from Feb 3- Feb 7

** Co did not specify what the warning was for

** Co says committed to resolve issue at the earliest

** Stock down 36% YTD

(Reporting by Komal Salecha)

(([email protected];))

Aug 21 (Reuters) - Hikal Ltd HIKA.NS:

• RECEIVES US FDA WARNING LETTER FOR JIGANI FACILITY

Source text: ID:nNSEbtCCzt

Further company coverage: HIKA.NS

(([email protected];;))

May 23 (Reuters) - Hikal Ltd HIKA.NS:

• HIKAL LTD - US FDA CLASSIFIES HIKAL'S JIGANI UNIT INSPECTION AS 'OAI'

Source text: ID:nNSEv3Vgp

Further company coverage: HIKA.NS

(([email protected];))

** Shares of pharmaceuticals company Hikal HIKA.NS fall 5.1% to 357.55 rupees

** Co says US Food and Drug Administration (USFDA) concludes inspection at Jigani unit in Bengaluru with six observations

** Co did not specify what the observations are

** Trading vol at 249,574 shares, compared to 30-day avg of 265,596 shares

** Stock extends YTD losses to 8.4%

(Reporting by Meenakshi Maidas in Bengaluru)

(([email protected];))

Feb 4 (Reuters) - Hikal Ltd HIKA.NS:

• HIKAL DEC-QUARTER CONSOL PROFIT 172 MILLION RUPEES

• HIKAL DEC-QUARTER CONSOL TOTAL REVENUE FROM OPERATIONS 4.48 BILLION RUPEES

Source text: ID:nBSE34JySy

Further company coverage: HIKA.NS

(([email protected];))

Nov 12 (Reuters) - Hikal Ltd HIKA.NS:

• HIKAL LTD SEPT-QUARTER CONSOL PROFIT 183 MILLION RUPEES

• HIKAL LTD SEPT-QUARTER CONSOL TOTAL REVENUE FROM OPERATIONS 4.53 BILLION RUPEES

Source text: ID:nBSEZnM9V

Further company coverage: HIKA.NS

(([email protected];))

** Shares of pharmaceutical intermediates maker Ami Organics AMIO.NS rise 3.8% before trimming gains; last up 1.4%

** Co on Friday said Japan's drug regulator - the Pharmaceutical and Medical Devices Agency - inspected co's manufacturing facility in Surat for good manufacturing practices and concluded without any critical observations

** Inspected facility involved in making intermediates of active pharmaceutical ingredients

** Co exports products to Japan among other regions; its export revenue contributed to 56% of the overall rev in FY24

** Stock up 10% YTD, while smaller peer Hikal HIKA.NS is down 2.2% so far this year

(Reporting by Manvi Pant in Bengaluru)

(([email protected]; +918447554364;))

** Shares of Shelter Pharma SHEH.BO up 7.6% to 52.7 rupees, its biggest intraday pct gain since May 3

** Pharmaceutical co got order worth $120,000 from Berlin International Medical Co

** SHEH is trading below its key 50-, 100- moving avgs

** Stock is down 4% YTD, compared to a ~3% surge and 6% decline in larger peers Ami Organics AMIO.NS and Hikal Limited HIKA.NS, respectively

** Stock is ~32% up from last August, when it made its market debut

(Reporting by Aleef Jahan in Bengaluru)

(([email protected]))

May 9 (Reuters) - Hikal Ltd HIKA.NS:

• MARCH-QUARTER CONSOL NET PROFIT 339.7 MILLION RUPEES VERSUS 360 MILLION RUPEES

• MARCH-QUARTER CONSOL TOTAL REVENUE FROM OPERATIONS 5.14 BILLION RUPEES VERSUS 5.45 BILLION RUPEES

Further company coverage: HIKA.NS

(([email protected];))

March 5 (Reuters) - Hikal Ltd HIKA.NS:

• HIKAL LTD- MD WAS NOT DETAINED AND NEITHER TAKEN INTO CUSTODY

• HIKAL LTD- AUTHORITIES HAVE MADE A SYMBOLIC ARREST ON PAPER OF MD, RELEASED ON BAIL IN 2022 CASE

Source text for Eikon: ID:nNSE2Kydl5

Further company coverage: HIKA.NS

(([email protected];))

Feb 23 (Reuters) - Hikal Ltd HIKA.NS:

• BOMBAY HIGH COURT DISPOSED OF WRIT PETITION OF CO CHALLENGING JURISDICTION OF PRINCIPAL BENCH OF NGT

• COURT GRANTED LIBERTY TO CO TO SEEK REMEDIES AS AVAILABLE UNDER LAW

Source text for Eikon: ID:nBSE2zlrr1

Further company coverage: HIKA.NS

(([email protected];))

** Shares of Hikal HIKA.NS down 2.9% to 288.8 rupees

** HIKA slid 3.8% earlier in the day to hit session's low at 286 rupees

** Chemical maker's Q3 consol net profit slumped ~39%, rev from ops dropped 17%

** More than 308,000 shares changed hands by 12:50 p.m. IST vs 30-day avg of 310,603

** So far this year stock has fallen ~5% after a 26% drop in 2023 - its second straight annual loss

(Reporting by Hritam Mukherjee in Bengaluru)

(([email protected];))

Feb 8 (Reuters) - Hikal Ltd HIKA.NS:

• HIKAL DEC-QUARTER CONSOL NET PROFIT 161.4 MILLION RUPEES VERSUS 264.1 MILLION RUPEES

• HIKAL DEC-QUARTER CONSOL TOTAL REVENUE FROM OPERATIONS 4.48 BILLION RUPEES VERSUS 5.40 BILLION RUPEES

Source text for Eikon: ID:nNSE9qYlQ8

Further company coverage: HIKA.NS

(([email protected];;))

Dec 29 (Reuters) - Hikal Ltd HIKA.NS:

• GUJARAT POLLUTION CONTROL BOARD DIRECTING CO TO PAY 174.5 MILLION RUPEES

Source text for Eikon: ID:nBSE7jmgZZ

Further company coverage: HIKA.NS

(([email protected];;))

Aug 8 (Reuters) - Hikal Ltd HIKA.NS:

• INDIA'S HIKAL LTD JUNE-QUARTER CONSOL NET PROFIT 69.2 MILLION RUPEES VERSUS LOSS 88.6 MILLION RUPEES

• HIKAL LTD JUNE-QUARTER CONSOL TOTAL REVENUE FROM OPERATIONS 3.88 BILLION RUPEES VERSUS 3.79 BILLION RUPEES

Source text for Eikon: ID:nBSE5Lg0Hp

Further company coverage: HIKA.NS

(([email protected];))

** Shares of Hikal Ltd HIKA.NS up as much as 12.1% to 317.50 rupees, their highest since March 16

** Stock rises after six consecutive sessions of declines

** Chemicals manufacturer posted a ~74% YoY surge in its March-qtr net profit, while revenue from ops rose 7.4% YoY

** Over 2.2 mln shares change hands by 09:46 a.m. IST, 10.4x the 30-day moving avg

** Stock down ~23% YTD vs a 22% decline last year

(Reporting by Kashish Tandon in Bengaluru)

(([email protected]))

May 29 (Reuters) - Hikal Ltd HIKA.NS:

• MARCH-QUARTER CONSOL PROFIT 360 MILLION RUPEES VERSUS PROFIT 207.1 MILLION RUPEES

• MARCH-QUARTER CONSOL TOTAL REVENUE FROM OPERATIONS 5.45 BILLION RUPEES VERSUS 5.02 BILLION RUPEES

Source text for Eikon: [ID:]

Further company coverage: HIKA.NS

(([email protected];))

May 15 (Reuters) - Hikal Ltd HIKA.NS:

• ANNOUNCES US FDA AUDIT WITH ZERO OBSERVATIONS

• INSPECTION AT CO'S PHARMACEUTICAL MANUFACTURING FACILITY AT PANOLI CONCLUDED WITH 'ZERO 483 OBSERVATIONS' FROM US FDA

Source text for Eikon: ID:nBSE3RNzxR

Further company coverage: HIKA.NS

(([email protected];;))